Logo-apb
Adv Pharm Bull. 2024;14(2): 378-387. doi: 10.34172/apb.2024.025
PMID: 39206390        PMCID: PMC11347738

Research Article

Fabrication of Anti-glaucoma Nanofibers as Controlled-Release Inserts for Ophthalmic Delivery of Brimonidine Tartrate: In Vivo Evaluation in Caprine Eye

Fariba Shaikhi Shoushtari 1 ORCID, Mohammadshakib Naghshbandy 1, Leila Rezaei 2, Saba Mehrandish 3 ORCID, Shahla Mirzaeei 4,5 * ORCID

Cited by CrossRef: 1


1- Abdel-Bar H, ElKashlan A, Madkour A, Abdallah M, Hamdi M, Ali I. Hyaluronic acid-mediated nanocomplexation enhances ocular retention and therapeutic efficacy of dorzolamide in a biodegradable gelatin insert. International Journal of Biological Macromolecules. 2026;355:151577 [Crossref]
2- Baghban R, Khalili M, Zareei A, Talebnejad M. Advancing glaucoma treatment with nanotechnology: a new frontier in ophthalmology. International Journal of Pharmaceutics. 2025;685:126210 [Crossref]
3- Abboud H, Zelkó R, Kazsoki A. Development of Practical Low-Volume Screening Method and Pharmacokinetic Simulation of Levofloxacin-Loaded Nanofiber Inserts for Sustained Ocular Therapy. Pharmaceutics. 2025;17(10):1343 [Crossref]
4- Chandel A, Kandav G. Insights into ocular therapeutics: A comprehensive review of anatomy, barriers, diseases and nanoscale formulations for targeted drug delivery. Journal of Drug Delivery Science and Technology. 2024;97:105785 [Crossref]
5- Pandey G, Kolipaka T, Yadav D, Methri S, Singh A, Natesan S, Srivastava S. Next-generation polymer-based nanofiber ocular inserts: fabrication innovations, therapeutic applications, regulatory perspectives, and future directions. International Journal of Pharmaceutics. 2026;695:126781 [Crossref]